Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

1.13
Delayed Data
As of 3:57pm ET
 -0.01 / -0.88%
Today’s Change
0.64
Today|||52-Week Range
2.05
-19.86%
Year-to-Date
No recent news for X T L Biopharmaceuticals Ltd.

Today’s Trading

Previous close1.14
Today’s open1.11
Day’s range0.99 - 1.28
Volume18,321
Average volume (3 months)5,756
Market cap$13.6M
Dividend yield--
Data as of 3:57pm ET, 06/29/2016

Growth & Valuation

Earnings growth (last year)-29.05%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book3.19

Competitors

 Today’s
change
Today’s
% change
BVXVBiondVax Pharmaceuti...-0.10-2.57%
ATOSAtossa Genetics Inc-0.00-0.38%
CYANCyanotech Corp-0.11-2.10%
EVOKEvoke Pharma Inc+0.32+4.80%
Data as of 4:00pm ET, 06/29/2016

Financials

Last reporting dateMarch 17, 2016
EPS forecast (this quarter)$0.00
Annual revenue (last year)$0.00
Annual profit (last year)-$3.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Raanana, Hamerkaz

Forecasts

Partner Offers

Search for Jobs